Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 185Neoplasms 11Prostate Adenocarcinoma 3Neoplasm Metastasis 3Adenocarcinoma 2Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Recurrence 1Prostatic Diseases 1Primary Dysautonomias 1PSA Level Greater Than Two 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Lymphatic Metastasis 1Lower Urinary Tract Symptoms 1Kidney Diseases 1Hypertension 1Hormone Sensitive Prostate Cancer 1Genital Neoplasms, Male 1Castration-resistant Prostate Cancer Patients with Oligometastases 1Carcinoma 1Advanced Prostate Cancer 1Advanced Prostate Adenocarcinoma 1

Interventions

Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Magnetic Resonance Spectroscopy 2radium Ra 223 dichloride 1peposertib 1fluoroazomycin arabinoside 1cabozantinib 1avelumab 1Radiotherapy, Image-Guided 1Radiation Dose Hypofractionation 1PITX2 protein, human 1Nomograms 1Nivolumab 1Metastasectomy 1Leuprolide 1Ipilimumab 1Indocyanine Green 1Goserelin 1Docetaxel 1DEAE-Dextran 1CTLA-4 Antigen 1Artificial Intelligence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × Leuprolide × Genitourinary × Clear all
NCT01076335 2016-09-19

Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
40 enrolled 3 charts
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡